A case of metachronous ascending colon cancer and synchronous primary rectal and duodenal cancer in a patient with Lynch syndrome

Authors

DOI:

https://doi.org/10.30978/GS-2024-4-68

Keywords:

metachronous cancer, synchronous primary rectal and duodenal cancer, surgical treatment, Lynch syndrome

Abstract

Multiple primary malignant tumours (MPMTs) are defined as the simultaneous or sequential occurrence of two or more primary malignant tumours in a single patient, which may originate from the same organ, paired organs, different parts of the same system, or different organs. Synchronous MPMTs develop within 6 months of the primary tumour, while metachronous ones occur more than 6 months later. The available sources have no information on metachronous or synchronous colorectal and duodenal cancer.

Objective —  to present treatment outcomes of a rare case of metachronous ascending colon cancer and synchronous primary rectal and duodenal cancer in a patient with Lynch syndrome.

A male patient, born in 1963, underwent a right‑sided hemicolectomy for ascending colon mucinous adenocarcinoma — stage III (рTN1M0) — in 2002. In the summer of 2022, he complained of pain in the right hypochondrium, nausea, general weakness, and blood in the stool. The examination revealed the presence of synchronous primary cancer in the rectosigmoid section and duodenal cancer. The decision to proceed with a two‑stage surgical intervention was based on the partial colonic obstruction. The first stage (September 08, 2022) included the anterior resection of the rectum with sigmo‑recto anastomosis (рТN2bM0, stage III, R‑0). The second stage (December 08, 2022) included the resection of a portion of the descending and lower horizontal parts of the duodenum with duodeno‑duodenoanastomosis, followed by Roux‑en‑Y gastrojejunostomy. The procedure entailed stitching the stomach in the prepyloric section, performing a cholecystectomy, and draining the abdominal cavity (duodenal adenocarcinoma with free margins: R‑0). The patient was diagnosed with Lynch syndrome based on immunohistochemistry screening results and genetic studies. After the first and second stages, the patient categorically refused to undergo a course of traditional adjuvant therapy. At the control CT scan 1.9 months after the last operation, there were no signs of prolongatio morbi. A rare case of synchronous rectal and duodenal cancer, demonstrating favourable treatment outcomes after two‑stage surgery without standard adjuvant therapy, is described. Patient follow‑up is ongoing; therefore, the results may change in the future.

 

Author Biographies

Y. M. Susak, Bogomolets National Medical University, Kyiv

MD, ScD, Prof., Head of the Department of Surgery with a Course of Emergency and Vascular Surgery

I. M. Leshchyshyn, Bogomolets National Medical University, Kyiv

PhD, Assoc. Prof. in the Department of Surgery with a Course of Emergency and Vascular Surgery

О. М. Lobanova, Kyiv City Clinical Emergency Hospital

MD

References

Hrinevych YuIa, Hanul VP, Chornyi VO ta in. Zvit pro rezultaty obmezhenykh klinichnykh vyprbuvan preparatu Amitozyn ukhvorykh na zloiakisni novoutvorennia ta vyvchennia yoho imunomoduliuiuchykh vlastyvostei. Kyiv, 2001, 17 s. http://www.potopalsky.kiev.ua/docs/pdf/zvit_amitoz-2001.pdf [in Ukrainian].

Osinskyi SP, Potopalska IuA, Potopalskyi AI. Vyvchennia protypukhlynnoi i modyfikuiuchoi aktyvnosti amitozynu pry kompleksnomu zastosuvanni Materialy mizhnarodnoho naukovo-praktychnoho forumu «Osnovy molekuliarno-henetychnoho ozdorovlennia liudyny i dovkillia» K. 2005 r. 196-199 [in Ukrainian].

Potopalskyi AI. Preparatы chystotela v byolohyy y medytsyne. Kyev. «Naukova dumka». 1992, 239 s. [in Ukrainian].

Abdeen Y, Al-Amer M, Taft E, Al-Halawani M. Four synchronous primary tumors in a male patient. J Cancer Res Ther. 2021 Jan-Mar;17(1):258-261. http://doi.org/10.4103/jcrt.JCRT_187_18. PMID: 33723165.

Amjad AI, Singhi AD, Balaban EP, Dudley B, Brand RE, Bahary N. First reported case of a squamous cell carcinoma arising in the duodenum in a patient with Lynch syndrome. Int J Clin Exp Pathol. 2014 Dec 1;7(12):8988-95. PMID: 25674277; PMCID: PMC4313961.

Buchbjerg T, Fristrup C, Mortensen MB. The incidence and prognosis of true duodenal carcinomas. Surg Oncol. 2015 Jun;24(2):110-6. http://doi.org/10.1016/j.suronc.2015.04.004. Epub 2015 Apr 22. PMID: 25936244.

Cheng HY, Chu CH, Chang WH, Hsu TC, Lin SC, Liu CC, Yang AM, Shih SC. Clinical analysis of multiple primary malignancies in the digestive system: a hospital-based study. World J Gastroenterol. 2005 Jul 21;11(27):4215-9. http://doi.org/10.3748/wjg.v11.i27.4215. PMID: 16015692; PMCID: PMC4615445.

Demandante CG, Troyer DA, Miles TP. Multiple primary malignant neoplasms: case report and a comprehensive review of the literature. Am J Clin Oncol. 2003 Feb;26(1):79-83. http://doi.org/10.1097/00000421-200302000-00015. PMID: 12576929.

Ene CV, Bulai CTLA, Geavlete P, Popescu RI, Vacaroiu IA, Georgescu DE, Isaconi IV, Munteanu MDLA, Ene CD, Militaru A, Geavlete B, Multescu R. New Insights into Lynch Syndrome: A Narrative Review. Chirurgia (Bucur). 2023 Dec;118(6):584-595. doi: 10.21614/chirurgia.2023.v.118.i.6.p.584. https://pubmed.ncbi.nlm.nih.gov/38228591/

Feller A, Matthes KL, Bordoni A, Bouchardy C, Bulliard JL, Herrmann C, Konzelmann I, Maspoli M, Mousavi M, Rohrmann S, Staehelin K, Arndt V; NICER Working Group. Correction to: The relative risk of second primary cancers in Switzerland: a population-based retrospective cohort study. BMC Cancer. 2020 Feb 3;20(1):87. http://doi.org/10.1186/s12885-020-6584-2. Erratum for: BMC Cancer. 2020 Jan 21;20(1):51. http://doi.org/10.1186/s12885-019-6452-0. PMID: 32013907; PMCID: PMC6996171.

Hammoudi N, Dhooge M, Coriat R, Leblanc S, Barret M, Bordacahar B, Beuvon F, Prat F, Maksimovic F, Chaussade S. Duodenal tumor risk in Lynch syndrome. Dig Liver Dis. 2019 Feb;51(2):299-303. http://doi.org/10.1016/j.dld.2018.10.005. Epub 2018 Oct 15. PMID: 30448460.

Hermant B, Gudrun A, Potopalsky AI, Chroboczek J, Tcherniuk SO. Amitozyn impairs chromosome segregation and induces apoptosis via mitotic checkpoint activation. PLoS One. 2013;8(3):e57461. http://doi.org/10.1371/journal.pone.0057461. Epub 2013 Mar 7. Erratum in: PLoS One. 2013;8(6). http://doi.org/10.1371/annotation/0b7ab40b-2246-4426-a98d-36b028029c5c. Herman, Bastien [corrected to Hermant, Bastien]. Erratum in: PLoS One. 2015 Feb 03;10(2):e0118039. http://doi.org/10.1371/journal.pone.0118039. PMID: 23505430; PMCID: PMC3591406.

Kapsinow R. Multiple primary cancer. A classification with report of cases. J La State Med Soc. 1962 Jun;114:194-200. PMID: 14453808.

Kato T, Suzuki K, Muto Y, Sasaki J, Tsujinaka S, Kawamura YJ, Noda H, Horie H, Konishi F, Rikiyama T. Multiple primary malignancies involving primary sporadic colorectal cancer in Japan: incidence of gastric cancer with colorectal cancer patients may be higher than previously recognized. World J Surg Oncol. 2015 Feb 7;13:23. http://doi.org/10.1186/s12957-014-0432-2. PMID: 25889477; PMCID: PMC4345022.

Meijer LL, Alberga AJ, de Bakker JK, van der Vliet HJ, Le Large TYS, van Grieken NCT, de Vries R, Daams F, Zonderhuis BM, Kazemier G. Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis. Ann Surg Oncol. 2018 Sep;25(9):2681-2692. http://doi.org/10.1245/s10434-018-6567-6. Epub 2018 Jun 26. PMID: 29946997; PMCID: PMC6097725.

Menahem B, Alves A, Regimbeau JM, Sabbagh C. Lynch Syndrome: Current management In 2019.J Visc Surg. 2019 Dec;156(6):507-514. http://doi.org/10.1016/j.jviscsurg.2019.07.009.

Miao K, Yu S, Ni J, Zhang X, Zhang L. Second primary tumor after immune checkpoint inhibitor therapy: A case report. Thorac Cancer. 2022 Apr;13(7):1076-1078. http://doi.org/10.1111/1759-7714.14327. Epub 2022 Feb 11. PMID: 35150077; PMCID: PMC8977149.

Steinemann DC, Bueter M, Schiesser M, Amygdalos I, Clavien PA, Nocito A.Management of anastomotic ulcers after Roux-en-Y gastric bypass: results of an international survey. Obes Surg. 2014 May;24(5):741-6. http://doi.org/10.1007/s11695-013-1152-3.

Tanjak P, Suktitipat B, Vorasan N, Juengwiwattanakitti P, Thiengtrong B, Songjang C, Therasakvichya S, Laiteerapong S, Chinswangwatanakul V. Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study. BMC Cancer. 2021 Sep 23;21(1):1045. http://doi.org/10.1186/s12885-021-08766-9.

Warren S, Gates O. Multiple primary malignant tumors, a survey of the literature and statistical study. Am J Cancer. 1932;16:1358-1414.

Yang XB, Zhang LH, Xue JN, Wang YC, Yang X, Zhang N, Liu D, Wang YY, Xun ZY, Li YR, Sun HS, Zhao LJ, Zhao HT. High incidence combination of multiple primary malignant tumors of the digestive system. World J Gastroenterol. 2022 Nov 7;28(41):5982-5992. http://doi.org/10.3748/wjg.v28.i41.5982.

Ying X, Zhang H, Chen B, Wu H, Bao L, Qian S, Ying X. Multiple metachronous rare primary malignant tumors: A case report. Thorac Cancer. 2019 Oct;10(10):2050-2053. http://doi.org/10.1111/1759-7714.13182. Epub 2019 Aug 27. PMID: 31454854; PMCID: PMC6775015.

Zhai C, Cai Y, Lou F, Liu Z, Xie J, Zhou X, Wang Z, Fang Y, Pan H, Han W. Multiple Primary Malignant Tumors - A Clinical Analysis of 15,321 Patients with Malignancies at a Single Center in China. J Cancer. 2018 Jul 16;9(16):2795-2801. http://doi.org/10.7150/jca.25482. PMID: 30123347; PMCID: PMC6096360.

Zhan X, He L, Song K, Cao S, Meng E, Wang Y. Case Report: Triple Primary Malignant Tumors of the Esophagus, Stomach, and Colon in a Patient With Genetic Analysis. Front Genet. 2021 Jul 9;12:676497. http://doi.org/10.3389/fgene.2021.676497. PMID: 34306021; PMCID: PMC8299121.

Zhang Z, Liu F, Qu Y, Qiu L, Zhang L, Yang Q. Second primary malignancy among malignant solid tumor survivors aged 85 years and older. Sci Rep. 2021 Oct 5;11(1):19748. http://doi.org/10.1038/s41598-021-99260-6. PMID: 34611235; PMCID: PMC8492691.

Zhu CL, Peng LZ. Clinical analysis of multiple primary gastrointestinal malignant tumors: A 10-year case review of a single-center. World J Gastrointest Oncol. 2024 Apr 15;16(4):1204-1212. http://doi.org/10.4251/wjgo.v16.i4.1204.

Downloads

Published

2024-12-30

How to Cite

1.
Susak Y, Leshchyshyn I, Lobanova О. A case of metachronous ascending colon cancer and synchronous primary rectal and duodenal cancer in a patient with Lynch syndrome. ЗХ [Internet]. 2024Dec.30 [cited 2025Feb.5];(4):68-75. Available from: http://generalsurgery.com.ua/article/view/322178

Issue

Section

Clinical Case